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Specific major histocompatibility complex (MHC) class I alleles are associated with an increased frequency of spontaneous con-
trol of human and simian immunodeficiency viruses (HIV and SIV). The mechanism of control is thought to involve MHC class
I-restricted CD8 T cells, but it is not clear whether particular CD8 T cell responses or a broad repertoire of epitope-specific
CD8 T cell populations (termed T cell breadth) are principally responsible for mediating immunologic control. To test the hy-
pothesis that heterozygous macaques control SIV replication as a function of superior T cell breadth, we infectedMHC-homozy-
gous andMHC-heterozygous cynomolgus macaques with the pathogenic virus SIVmac239. As measured by a gamma interferon
enzyme-linked immunosorbent spot assay (IFN- ELISPOT) using blood, T cell breadth did not differ significantly between ho-
mozygotes and heterozygotes. Surprisingly, macaques that controlled SIV replication, regardless of their MHC zygosity, shared
durable T cell responses against similar regions of Nef. While the limited genetic variability in these animals prevents us from
making generalizations about the importance of Nef-specific T cell responses in controlling HIV, these results suggest that the T
cell-mediated control of virus replication that we observed is more likely the consequence of targeting specificity rather than T
cell breadth.
Studies of human immunodeficiency virus (HIV) “elite con-trollers” implicate major histocompatibility complex (MHC)
class I genes, and by extension the CD8 T cell responses they
restrict, in immunologic containment of viral replication (25).
Identifying the specific attributes ofCD8Tcell responses that are
fundamental to HIV control could clarify whether immunologic
containment is possible for the majority of infected individuals
who do not become elite controllers and could facilitate the design
of prophylactic vaccines that elicit cellular immune responses ca-
pable of mediating viral control.
A T cell response directed against a large number of distinct
viral epitopes, i.e., high “T cell breadth,” has frequently been pro-
posed to be a favorable immunologic attribute (21, 30). This
breadth hypothesis is attractive because it is conceptually simple:
if immunologic control fails because too few epitope-specific
CD8 T cell responses are elicited, interventions designed to
broaden the CD8 T cell response should be beneficial. The data
in support of the breadth hypothesis are mixed. Perhaps the most
striking supporting evidence is the observation that individuals
who are MHC homozygous experience faster disease progression
than fully heterozygous individuals (8, 29). Because MHC-
heterozygous individuals have twice as many different MHC class
I molecules available to bind and present HIV-derived peptides,
the theoretical breadth of their CD8 T cell response at any mo-
ment is double that of theirMHC-homozygous counterparts. Sev-
eral studies have suggested that broadly directed CD8 T cell re-
sponses are associated with low virus loads and/or high CD4 T
cell counts (9, 11, 12). However, other studies of HIV-infected
humans have yielded conflicting results (1, 16, 19). Furthermore,
Indian rhesusmacaques that expressMamu-B*17, anMHC class I
allele associated with simian immunodeficiency virus (SIV) elite
control, do not segregate into controllers and progressors based
on the breadth of their CD8T cell responses (13, 20). All of these
studies are confounded by complex host MHC genetics, which
contributes to the persisting controversy.
Unlike humans and other macaques, Mauritian cynomolgus
macaques (MCM) are geographically isolated and descend from a
small founder population that arrived onMauritius within the last
500 years (17). Consequently,MCMhave extremely limitedMHC
genetic diversity, with only sevenmajor haplotypes (6, 22), termed
M1 through M7. The MHC alleles on each of these seven haplo-
types are known.
In an earlier study, we showed that MHC-heterozygous MCM
maintained lower chronic-phase viremia than MHC-homozy-
gous animals, although this was in a cohort enriched for the M3
haplotype (24). Here, we expand this study to include 27 SIV-
mac239-infected MCM representing all seven MHC haplotypes.
The previous observation that M3 homozygous macaques have
higher viral loads than do M1/M3 heterozygous macaques was
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confirmed. Overall, however, we found no significant correlation
betweenMHC zygosity and viral load. Control of SIV replication,
defined as a plasma viral load below 1,000 RNA copies/ml, was
observed only in MCM possessing the M1 or M7 haplotypes, re-
gardless of MHC zygosity. Moreover, animals that successfully
controlled viral replication consistently mounted durable, immu-
nodominant responses against a region of the Nef protein. These
responses were subdominant or absent in animals that failed to
control SIV replication.
MATERIALS AND METHODS
Animals and infections. This study was based on an initial prospective
evaluation of 18 MCM (6 M1/M1, 6 M1/M3, and 6 M3/M3). Following
our initial study, we included 10 additional MCM of various haplotypes
(Table 1). Animals were infected intrarectally with molecularly cloned
SIVmac239 nef-open virus (50% tissue culture infective dose [TCID50],
from 100 to 50,000), accession number M33262 (27). All animals were
cared for by theWisconsin National Primate Research Center (University
of Wisconsin, Madison, WI) according to experimental protocols ap-
proved by the University ofWisconsin Graduate School Animal Care and
Use Committee. A panel of microsatellite markers spanning the MHC
region was used to determine individual haplotypes as described previ-
ously (31). Genotypes were confirmed using Roche/454 pyrosequenc-
ing (6).
Plasma viral load analysis.Virion-associated SIV RNA in plasma was
measured using a real-time (RT) quantitative reverse transcription-PCR
assay, essentially as described previously (10).
Peptides. The NIH AIDS Research and Reference Reagent Program
(Germantown, MD) provided 15-mer peptides with an 11-residue over-
lap spanning the full SIVmac239 proteome. Additional peptides used for
mapping Nef 196-203 HW8 were synthesized by ProImmune Inc. (Sara-
sota, MN). All peptide sequences were derived from the SIVmac239 ge-
nome.
IFN- ELISPOTs. Gamma interferon enzyme-linked immunosor-
bent spot assays (IFN- ELISPOTs) were conducted according to the
manufacturer’s protocol as described previously (7). Briefly, peripheral
blood mononuclear cells (PBMC) were isolated using Ficoll-Paque Plus
(GE Healthcare Bioscience, Uppsala, Sweden) density centrifugation
from whole blood containing EDTA at 24 and 52 weeks postinfection.
Cells were suspended inRPMI 1640 (HyClone, Logan,UT) supplemented
with 10% fetal calf serum, 1% antibiotic/antimycotic (HyClone), and 1%
L-glutamine (HyClone) (R-10 medium) and then added at 105 cells per
well in 100 l of R-10 to a precoated monkey IFN- ELISPOT Plus plate
(Mabtech Inc., Mariemont, OH) with the peptides of interest. Tradi-
tional, full proteome peptides contained pools of 10 peptides at a concen-
tration of 10 M or 1 M each. To identify single peptides that elicited
IFN- release, we performed a second ELISPOT in tandem using matrix
pools containing a randomized assortment of 10 peptides at a concentra-
tion of 10 M each. Concanavalin A (10 M) was used as a positive
control in duplicate wells. A minimum of six wells (three samples in du-
plicate) did not receive any stimulant and served as negative controls. All
samples were repeated in duplicate or triplicate. Wells were imaged using
an AID ELISPOT reader, and spots were counted using an automated
program with fixed parameters. For the assay to be considered successful,
a minimum of 100 spots was required in each positive-control well. Ex-
perimental responses exceeding the arithmetic mean of the negative-con-
trol wells plus 2 standard deviations were considered positive. The limit of
detection was set at 70 spot-forming cells (SFCs) per 106 PBMC. To ac-
count for the difference in SFCs between animals, responses were normal-
ized using the following equation: 100 (SFCs from a positive peptide)/
(SFCs from all positive peptides).
Viral sequencing.Viral RNA was isolated from cell-free plasma using
the QIAmp MinElute Virus Spin kit (Qiagen, Valencia, CA). Four over-
lapping PCR amplicons spanning the entire SIVmac239 genome were
then amplified using the SuperScript III One-Step RT-PCR system with
Platinum TaqHigh Fidelity (Invitrogen, Carlsbad, CA) as described pre-
viously (2). Products were gel purified and fragmented with the Nextera
DNASample Prep kit (Epicentre,Madison,WI), and thenmultiplex iden-
tifier (MID) tags and adapter sequences for Roche/454 pyrosequencing
were added. Purified fragments were pyrosequenced using a Roche/454
GS Junior instrument. Variants present in1% of reads were considered
authentic, a threshold that we had previously determined empirically (2).
Amino acid alignments were derived from the sequence read data using a
custom data analysis pipeline in Galaxy, an open-source system for pro-
cessing next-generation sequence data previously described (3, 4, 14, 23).
ICS. Peptide-specific cytokine release by CD8 T cell lines was de-
tected by flow cytometry as described previously (5). Briefly, peptide-
pulsed B-lymphoblastoid cell line (BLCL) or MHC class I transferents
were incubated with CD8 T cell lines specific for Nef 196-203 HW8 in
the presence of brefeldin A (10 g/ml; Sigma-Aldrich, St. Louis, MO).
After 5 h, the cells were surface stainedwith the directly conjugatedmono-
clonal antibodies (MAbs) CD3-Alexa Fluor 700 (clone SP34-2; BD Bio-
sciences, San Jose, CA) and CD8-Pacific Blue (clone RPA-T8; BD Bio-
sciences) and then washed, fixed, and permeabilized prior to intracellular
staining with -IFN--fluorescein isothiocyanate (IFN--FITC) (clone
4S.B3; BD Biosciences) and tumor necrosis alpha-alpha-phycoerythrin
(TNF--PE) (cloneMAb11; BD Biosciences). Stained cells were fixed in
2% paraformaldehyde and acquired using an LSRII flow cytometer (BD
Biosciences). Data were analyzed using FlowJo software version 8.8.2
(TreeStar, Ashland, OR). All intracellular cytokine staining (ICS) results
were confirmed in at least two individual experiments.
Tetramer staining. Soluble tetrameric peptide-MHC class I com-
plexes were generated as described previously (26). Cryopreserved PBMC
were resuspended in 150 l of R-10 with 5 g/ml of phycoerythrin (PE)-
TABLE 1 Animals used in study, ordered by plasma viral load
Animal
name Haplotype
Infection
dose
(TCID50)
Data from 52 weeks postinfection
Log viral
load
No. of SFCs per
106 PBMC
No. of T cell
responses
cy0321 M1/M1 50,000 1 5,780 6
cy0322 M1/M1 50,000 1
cy0326 M1/M3 50,000 1 2,250 6
cy0323 M1/M1 50,000 1.7 1,410 5
cy0330 M1/M3 50,000 1.7 180 1
cy0342 M1/M2 50,000 1.7 1,700 9
cy0389 M4/M7 1,000 1.7 405 4
cy0390 M7/M7 500 1.7 495 3
cy0327 M1/M3 50,000 2 2,700 5
cy0332 M3/M3 50,000 4 6,450 7
cy0334 M3/M3 50,000 4 6,620 5
cy0335 M3/M3 50,000 4 2,140 2
cy0331 M1/M3 50,000 4.1 7,280 6
cy0325 M1/M1 50,000 4.3 2,880 4
cy0354 M3/M5 1,000 4.4 805 4
cy0320 M1/M1 50,000 4.6 1,510 3
cy0324 M1/M1 50,000 4.7 730 3
cy0351 M2/M4 100 4.8 1,510 8
cy0337 M3/M3 50,000 4.9 400 4
cy0328 M1/M3 50,000 5.1 2,930 3
cy0350 M2/M2 500 5.4 715 4
cy0355 M1/M5 500 5.4 1,480 7
cy0353 M3/M5 100 5.6 3,700 9
cy0356 M1/M6 1,000 5.7 1,130 3
cy0329 M1/M3 50,000 5.9 9,160 7
cy0333 M3/M3 50,000 6 3,710 2
cy0352 M2/M4 100 6.1 50 1
cy0336 M3/M3 50,000 6.3 540 2
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conjugated tetramer for 20 min at 37°C and washed once with fluores-
cence-activated cell sorter (FACS) buffer. Subsequently, cells were surface
stained with CD3-Alexa Fluor 700, CD14 ECD (clone RMO52; Beck-
manCoulter),CD19 ECD (clone J4.119, BeckmanCoulter), andCD8-
Pacific Blue and then washed and fixed with 2% paraformaldehyde.
Stained cells were acquired using an LSRII flow cytometer (BD Biosci-
ences) and data analyzed using FlowJo software version 8.8.2.
Statistical analysis. Replicates were graphed using GraphPad Prism
(GraphPad Software, La Jolla, CA). A two-way or one-way analysis of
variance (ANOVA) with Tukey’s multiple-comparison posttest was used
to compare the columns and determine significance. Correlations were
also assessed in GraphPad Prism assuming Gaussian populations. Bars on
graphs represent the standard errors of the means.
RESULTS
MCMwith low viral loads do not have increased T cell breadth.
We analyzed a cohort of 27 MCM infected with SIVmac239; each
of the major MHC haplotypes, M1 through M7, was expressed in
at least one of these animals (Table 1). The cohort included six
M1/M1 homozygous macaques, six M1/M3 heterozygous ma-
caques, and six M3/M3 homozygous macaques. Nine of the 27
MCM, including three M1/M1 homozygotes, four M1 heterozy-
gotes, one M7/M7 homozygote, and one M7 heterozygote, con-
sistently maintained low plasma viral loads (103 copies of viral
RNA per ml plasma) in the chronic phase of infection through 52
weeks postchallenge (Fig. 1A). In agreement with our previous
study (24),M3/M3 homozygousMCM fared poorly, with none of
these animals exhibiting chronic-phase viral load control (Fig.
1B). Lowviral loads in four homozygousMCM(threeM1/M1 and
one M7/M7) reduced the mean viral load of the entire homozy-
gous group, and as a result, there was no significant difference in
mean viral loads between heterozygous and homozygousMCMat
52 weeks postinfection.
SIV control in four MHC-homozygous macaques was some-
what unexpected but fortuitous, as it allowed us to examine the
attributes of T cell responses in the context of both MHC-
homozygous and MHC-heterozygous viral control. We first ex-
amined T cell breadth at 24 and 52 weeks postinfection to test the
hypothesis that controllers mount T cell responses targeting a
greater number of epitopes than animals that fail to control SIV-
mac239.We stimulated freshly isolated PBMCwith peptide pools
spanning the entire viral proteome and measured IFN- produc-
tion using ELISPOTs. Cells fromone controller, cy0322, could not
be analyzed by IFN- ELISPOT due to a high level of nonspecific
cytokine secretion.
To examine T cell breadth, we tabulated the number of T cell
responses targeting distinct peptide pools at 52 weeks postinfec-
tion. Each animal made between one and nine distinct T cell re-
sponses. Neither MHC zygosity nor SIV controller status corre-
latedwith the breadth of themeasuredT cell response (Fig. 2A and
B). We also assessed the strength of the total SIV-specific T cell
response by summing the magnitudes of individual T cell re-
sponses observed at 52 weeks postinfection. There was no corre-
lation between the total response magnitude, as measured by
SFCs per million PBMC, and viral load at 52 weeks postinfection
(Fig. 2C).
Some responses were detected at 24 weeks postinfection but
not at 52weeks, and vice versa. Therefore, to approximate the total
T cell breadth in each animal over time, we determined the total
number of distinct T cell responses detected at either or both of
these time points (Fig. 2D). For technical reasons, data are not
available from six animals (two M1/M1, two M1/M3, and two
M3/M3). When considering both time points in aggregate, the
measured breadth increased slightly, up to 13 T cell responses per
animal. Heterozygous MCM had slightly more chronic phase T
cell responses than homozygous MCM in this analysis, but the
difference was not significant. Again, the number of cumulative
chronic-phase T cell responses did not appear to correlate with
SIV control (Fig. 2E).
MCM with low viral loads share similar immunodominant
CD8 T cell responses. CD8 T cell responses against particular
epitopes in individual HIV and SIV proteins have been associated
with viral control. Indeed, the benefits of CD8 T cell responses
specific forGag, Pol, Vif, Vpr, Vpu, Tat, Rev, Env, and/orNef have
been championed by various studies and in various contexts (15,
16, 18, 28). We therefore analyzed the ELISPOT data described
above to examine CD8 T cell responses by protein target.
First, we compared T cell breadth at the protein level in con-
trollers and progressors, determining the number of distinct pep-
tides derived from each viral protein targeted at both 24 and 52
weeks postinfection (Fig. 3A and B, respectively). Notably, a sim-
ilar level of T cell breadth was observed over the course of time for
each protein. The relative number of Nef-specific T cell responses
was significantly greater in MCM with low viral loads (P  0.01
FIG 1 Effects of heterozygosity on chronic-phase viral loads. (A) Mean viral loads (number of viral RNA copies per ml plasma) for all 27 MCM at 52 weeks
postinfection. (B)Mean viral loads for a subgroup of 18MHC-matched (sixM1/M1, sixM1/M3, and sixM3/M3)MCM at 2, 12, 21, and 52 weeks postinfection
with SIVmac239. The horizontal dashed line represents the threshold of viral control as defined for this cohort (1,000 copies/ml). There were no statistically
significant differences between the different haplotypes.
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and P 0.001 at 24 and 52 weeks postinfection, respectively). In
contrast, the relative number of Env-specific T cell responses was
significantly (P 0.05 at both time points) greater in MCM with
high viral loads.
Next, to identify which proteins immunodominant T cell pop-
ulations targeted, we examined the percent contribution of each T
cell response to the total SIV-specific response. Within each ani-
mal, the dominant T cell responses were mainly directed against
one of three proteins: Gag, Env, orNef. Interestingly, amajority of
MCMwith low viral loads (8/10 and 6/8 at 24 and 52weeks postin-
fection, respectively) mounted dominant T cell responses against
epitopes in theNef protein. In contrast, Nef was not the dominant
target in any progressors at 24 weeks postinfection, and only one
progressor made a dominant Nef-specific T cell response at 52
weeks postinfection (Fig. 3C and D).
To extend these findings, we determined the regions within
FIG 2 The number and strength of T cell responses detected by IFN- ELISPOT do not correspond to viral load or MHC haplotype. (A) Number of positive T
cell responses in 26MCMat 52 weeks postinfection separated into controller, noncontroller, homozygote, and heterozygote populations. (B) Comparison of the
number of distinct T cell responses and viral loads at 52weeks postinfection. (C) Sumof all SIVpeptide-specific SFCs permillionPBMCseparated into controller,
noncontroller, homozygote, and heterozygote populations at 52 weeks postinfection. (D) Cumulative (24  52 weeks postinfection) chronic-phase T cell
responses in 20MCM separated into controller, noncontroller, homozygote, and heterozygote populations. (E) Comparison of the number of cumulative T cell
responses and viral loads at 52 weeks postinfection.
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Nef that were recognized by these T cell responses. In total, seven
Nef-specific T cell epitopes were identified. At 24 weeks postinfec-
tion, T cell responses against two epitopes, Nef 193-203 and Nef
253-263, were detected more frequently and accounted for a
greater proportion of the total virus-specific response in control-
lers than in progressors (Fig. 3E). By 52 weeks postinfection, only
the T cell response against Nef 193-203 accounted for a signifi-
cantly higher proportion of the total SIV-specific response in
controllers versus progressors (Fig. 3F). The two M7 control-
lers each mounted a T cell response against Nef 213-223, but
due to the small number of animals with the M7 haplotype, the
significance of this observation could not be determined. In-
terestingly, all three putatively beneficial responses clustered in
a narrow region near the carboxy terminus of Nef, and two of
them, Nef 193-203 and Nef 213-223, were restricted by MHC
class I A alleles (Fig. 4).
High viral load is associatedwith rapid accumulation of sub-
stitutions in Nef 196-203. The observation that a subset of the
M1/M1 homozygous and M1/M3 heterozygous MCM controlled
SIVmac239 andmounted strong responses against Nef 196-203 is
paradoxical. Why did the other animals with identical MHC ge-
netics not recognize this epitope? To explore this issue, we first
confirmed the MHC restriction of Nef 196-203, the minimal
optimal epitope. We constructed transferents expressing Mafa-
A1*063:01, -A4*01:01, -B*104:01, or -B*134:02 and used them in
an intracellular cytokine staining assay (Fig. 4). A CD8T cell line
specific for Nef 196-203 HW8 released cytokines when stimulated
by peptide-pulsed, MHC-matched BLCLs as well as transferents
expressing only Mafa-A1*063.
One potential explanation for the apparent absence of re-
sponses against Nef 196-203 HW8 in some chronically infected
animals expressing the M1, M2, or M3 haplotypes is that SIV
effectively escapes from CD8 T cells recognizing this epitope
early during infection in some, but not all, animals. Accordingly,
we examined whether viruses isolated from the subgroup of six
M1/M1 homozygous, six M1/M3 heterozygous, and six M3/M3
homozygous MCM accumulated amino acid substitutions in this
region at 12 weeks postinfection. OneM1/M1 homozygousMCM
FIG 3 The number and magnitude of T cell responses to Nef peptides during chronic infection differ between controllers and progressors. (A and B) Number
of T cell responses per SIV protein in controllers and progressors at 24 (A) and 52 (B) weeks postinfection. Controllers (animals with viral loads of103 RNA
copies/ml plasma) target significantly more Nef peptides than do progressors (P  0.01), while progressors target significantly more Env peptides than do
controllers (P 0.05). (C andD)Proportion of the total T cell response directed against each SIVprotein in each animal at 24 (C) and 52 (D)weeks postinfection.
(E and F) Individual T cell responses within the Nef protein at 24 (E) and 52 (F) weeks postinfection. MCM with low viral loads mounted significantly larger
responses against Nef 193-203 at both 24 and 52 weeks postinfection (P 0.001 in each case).
Budde et al.
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that maintained low viral loads could not be analyzed. Interest-
ingly, viruses from all five controllers almost exclusively displayed
wild-type sequence acrossNef 196-203HW8,while only 2/12 pro-
gressors harbored viral populations with dominant wild-type se-
quence at this epitope (Fig. 5A). The frequency of wild-type Nef
196-203 HW8 correlated significantly with chronic-phase viral
loads at 52 weeks postinfection (Fig. 5B).
To confirm that differential CD8 T cell pressure was driving
viral escape at Nef 196-203 HW8 in progressors prior to 12 weeks
postinfection, we examined response kinetics using the corre-
sponding peptide-MHC class I tetramer. Although not signifi-
cantly different, progressors tended to have higher frequencies of
Nef 196-203 HW8 tetramer-positive cells at 8 weeks postinfection
than controllers (Fig. 5C). Collectively, these observations suggest
that early events in viral infection, specifically the timing of CD8
T cell responses and viral escape, may have a significant impact on
whether or not individuals are able to maintain low viral loads
during chronic infection.
DISCUSSION
Full heterozygosity in MHC class I alleles is associated with de-
layed progression to AIDS (8). However, the complex MHC ge-
netics of humans and Indian rhesus macaques have frustrated
efforts to discern the underlying mechanism of this association.
Two possibilities have received considerable attention. One is that
fully heterozygous individuals simply have a greater likelihood of
possessing one or more protectiveMHC class I alleles (16), imbu-
ing these individuals with the ability to mount unusually effica-
cious CD8 T cell responses. A second explanation is that at any
moment, cells from MHC-heterozygous individuals present a
broader array of virus-derived epitopes than do homozygous
ones, allowing a larger number of distinct CD8T cell specificities
to target infected cells. A broader T cell repertoire may simply be
more robust, i.e., better able tomaintain control over a diversity of
viral variants, than a narrow one. These mechanisms are not mu-
tually exclusive. Our data suggest that in the model studied here,
SIV-infected MCM, MHC heterozygosity maximizes the likeli-
hood of having an allele that restricts one or more durable CD8
T cell responses that correlate with viral control. To our knowl-
edge, this is the first comprehensive demonstration that directly
examined both of these possibilities in the same study, leading to
the conclusion that in this model favorable CD8 T cell responses
and not epitopic breadth per se influence the heterozygote advan-
tage.
Care must be taken when assessing T cell breadth using ex vivo
FIG 4 Identification of the Nef 196-203 HW8 epitope. (A) MHC-matched BLCLs were pulsed with serial dilutions of prospective optimal peptides and
cocultured with a Nef 196-203 HW8-specific T cell line. Activation of CD8 T cells was measured by ICS using IFN--FITC and TNF--PE.When responses
were normalized to the percentage of the maximum response, Nef 196-203 HW8 was determined to be the optimal epitope. (B) MHC class I transferent K562
antigen-presenting cells were pulsed with cognate peptide and cocultured with a Nef 196-203 HW8-specific T cell line. Activation of CD8 T cells was measured
by ICS as described for panel A. Nef 196-203 HW8 was found to be restricted by Mafa-A1*063. Results are representative of at least two separate experiments.
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immunologic assays. We measured T cell breadth by IFN-
ELISPOT in blood samples, but it is possible that the breadth of
the CD8 T cell response in other anatomic compartments may
be different. In addition, the ELISPOT method measures only a
single functional attribute of T cell responses, i.e., IFN- secretion,
and may therefore underestimate those T cell populations that
primarily elaborate other effector molecules. It seems unlikely,
however, that these caveats would generate a systematic bias lead-
ing to the detection of greater T cell breadth only in heterozygous
individuals. Furthermore, all ex vivo assays suffer to a greater or
lesser extent from a lack of sensitivity. It is possible that bona fide
responses below the limit of ELISPOT detection exist, and we
cannot exclude the possibility that a difference in CD8 T cell
breadth exists among such minor responses.
It is important to note that while we examined T cell responses
at two different time points, we could not rigorously evaluate
cumulative T cell breadth in this study.We stopped the study at 52
weeks postinfection, before the development of AIDS. It is possi-
ble that, given enough time, the heterozygous animals would sup-
press virus replication for a longer time than their homozygous
counterparts, perhaps because some CD8 T cell specificities can
be engaged in heterozygotes only after the failure of frontline re-
sponses detected in the first year. The importance of cumulative T
cell breadth may therefore become apparent only on time scales
longer than that of the present study, and importantly, cumulative
T cell breadth could give heterozygous macaques longer disease-
free survivorshipwithout affecting the level of SIV replication. It is
also possible that T cell responseswould be affected if different SIV
strains, instead of a single clonal virus, were used.
Previously, we demonstrated that MHC-heterozygous MCM
maintained lower chronic-phase viremia than MHC-homozy-
gous animals in a cohort heavily enriched for theM3haplotype. In
the present study, we again observed that M3 homozygous ma-
caques had higher viral loads than did M1/M3 heterozygous ma-
caques (24). Surprisingly, however, we found no significant cor-
relation between MHC zygosity and viral load when examining
MCM of all seven haplotypes. This does not indicate that the
heterozygous advantage does not exist in HIV-seropositive co-
horts. Instead, considering the limited genetic diversity of this
population, we suspect that our results are strongly influenced by
the presence of two protective haplotypes that associate with du-
rable viral control regardless of zygosity. Despite this limitation,
the MCM system will allow us to dissect the differences between
“favorable” and “unfavorable” CD8T cell responses that are and
are not associated with virologic control in future experiments.
Further, due to the limited genetic diversity of bothMCM and the
clonal pathogenic virus SIVmac239, we will be able to more accu-
rately assess how stochastic immunological and viral events influ-
ence durable control.
Additional studies will be required to understand why MHC-
FIG 5 High viral loads are associated with the rapid accumulation of substitutions in Nef 196-203. (A) The wild-type (WT) frequency of Nef 196-203 HW8was
examined by 454 pyrosequencing at 12 weeks postinfection. There was a significant difference (P  0.01) in the frequency of wild-type Nef 196-203 HW8
sequences between controllers and progressors. (B) Comparison of wild-type Nef 196-203 HW8 sequence frequency at 12 weeks postinfection and viral loads at
52weeks postinfection. (C)Nef 196-203HW8-specificCD8T cell populations quantified by tetramer staining. Althoughmost progressorsmounted substantial
responses to this epitope by 8 weeks postinfection, there were no significant differences between controllers and progressors at any time point.
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identical animals exhibited different patterns of CD8 T cell im-
munodominance, particularly with regard to M1 macaques in
which a dominant Nef-specific response is correlated with viral
control. The simplest explanation is that vigorous T cell responses
against this epitope were mounted in all animals, with immune
escape variants arising rapidly only in a subset of the animals,
effectively “knocking out” a favorable response. If this is true, then
the ability of an individual to contain viral replication durably
may be at the mercy of stochastic events that are impossible to
predict a priori. Recently, we demonstrated “conditional” T cell
escape during the first weeks of SIVmac239 infection, in which the
selection of escape variants within an immunodominant epitope
was influenced by the selection of escape variants elsewhere in the
genome (23). Such conditional escape could be resolved only by
using a clonal virus, studying the initial responses that select im-
mune escape variants during acute infection, and examining
MHC-defined animals. Similar interepitope relationships may
pertain to chronic infection and are amenable to identification
with substantial data sets that could be generated relatively easily,
using deep-sequencing methodologies such as those employed
here.
Claims that specific domains of the HIV or SIV proteome rep-
resent magic bullets as universally effective CD8 T cell targets
should be viewed skeptically. Nonetheless, it is possible that some
epitopes maymake more effective targets than others. Indeed, the
benefit of CD8 T cell responses specific for Gag has been cham-
pioned by various studies and in various contexts (15, 16, 18, 28).
One potential mechanism for this effect is that Gag is subject to
strong evolutionary constraints and escape mutations in Gag fre-
quently exact a cost to viral fitness. In our study, viral control
correlated with a single response directed against Nef 196-203
HW8. There may be isolated examples of Nef-specific responses
that are similarly protective in HIV-seropositive individuals but
whose effect is masked in population studies with heterogeneous
HLA representation. Certain regions of Nef may also be under
significant constraint. Conversely, there may be Gag-specific
CD8 T cell responses in other macaque populations that can
control SIV viral loads but are restricted byMHC class I alleles not
represented in MCM.
In conclusion, our data indicate that in SIV-infected MCM
there is no relationship between viral control and either the num-
ber or themagnitude of CD8T cell responses at a givenmoment.
Instead, controllers shared stable CD8 T cell recognition of
epitopes located in a small region of the SIV Nef protein. The
presence of theMHC class I allele capable of restricting these ben-
eficial epitopes is not, by itself, enough to confer control of plasma
viremia. Rather, durable control may depend on both definable
parameters, such as the presence of a protectiveMHC class I allele,
and stochastic ones, such as the direction and rate of viral evolu-
tion under CD8 T cell pressure. It seems likely that both T cell
breadth and durable effective targeting of selected, evolutionarily
constrained epitopes can contribute to control of AIDS virus rep-
lication by CD8 T cells; the critical goal of outflanking the ability
of the virus tomutationally escapeT cell responses can be achieved
by multiple mechanisms. However, in the SIV-infected MCM
studied here, stable CD8T cell recognition of epitopes located in
a small region of the SIV Nef protein appears to be the key factor
associated with control of viral replication.
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